DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

5.08 -0.14 (-2.68%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $5.08 -2.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.27
Previous Close $5.22
Daily Range $5.03 - $5.32
52-Week Range $3.10 - $7.45
Market Cap $353.3M
P/E Ratio -8.56
Dividend (Yield) $0.00 (0.0%)
Volume 634,039
Average Daily Volume 918,419
Current FY EPS -$0.02

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

2nd Half Of 2014 Biotechnology Catalysts--Part 4

Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog

US Stock Futures Signal Higher Start On Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q2 2014 Results - Earnings Call Transcript

Progenics Pharmaceuticals (PGNX) Q2 2014 Results - Earnings Call Webcast

Earnings Scheduled For August 8, 2014

Will Progenics (PGNX) Disappoint this Earnings Season? - Analyst Blog

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

An Inefficient Stock Market Will Catch Up To Progenics

See More PGNX News...

PGNX's Top Competitors

PGNX $5.08 (-2.68%)
Current stock: PGNX
AMGN $144.01 (1.40%)
Current stock: AMGN
GILD $105.96 (0.03%)
Current stock: GILD
BIIB $329.24 (-0.23%)
Current stock: BIIB